Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 45 min ago
PreprintCC BYmedRxiv

PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial

  1. 1University College London

Abstract

This document describes the Statistical Analysis Plan (SAP) for PETRA, a randomised controlled trial in people with generalised anxiety disorder comparing pregabalin plus an antidepressant and standard care, with placebo plus an antidepressant and standard care, with respect to the primary outcome of the GAD-7 score at week 12.

Related

  1. Dietary Enhancement for Iron Deficiency and Anaemia Treatment (DEFeAT): study protocol for a randomised controlled trial to assess the effect of a mineral-enriched powder on iron deficiency in women of reproductive age
    J. L. Burns, H. Scott, L. Mbuagbaw +5
    medRxivPreprintAll rights reservedFull textNutritionmedRxiv
  2. Optimised blended treatment for alcohol use disorder (OptiBlend) in Dutch outpatient addiction care: study protocol for a three-arm randomised controlled trial
    Lisa Elze Imhof, Puck Theresa Gerarda Maria Veldman, Eline Josephina Maria Bol +6
    BMJ OpenPeer-reviewedLicence not statedGeneral medicineCrossref
  3. Efficacy of ferrous fumarate with elemental iron 60 mg alternate-day, 120 mg alternate-day vs 60 mg once a day therapy in the treatment of iron deficiency anaemia: study protocol for a randomised controlled trial
    Chamila Mettananda, Randula Mallawa, Naveen Fernando +8
    TrialsPeer-reviewedCC BY-NC-ND 4.0Clinical trials & evidence synthesisCrossref
  4. Adalimumab versus placebo as add-on to standard therapy for non-infectious uveitis in the United Kingdom: the ASTUTE randomised controlled trial with treatment run-in
    Andrew D. Dick, Barnaby C. Reeves, Nicholas A.V. Beare +82
    EClinicalMedicinePeer-reviewedCC BYFull textGeneral medicineEurope PMCCrossref
  5. Nurse-Led treatment strategy based on asthma score and oxygen requirement in children with acute reversible bronchoconstriction: A randomised controlled non-inferiority trial
    Sam Louman, Britt Foreman, Lidy van Lente +5
    PLOS OnePeer-reviewedCC BYFull textGeneral chemistryPharmacology & toxicologyPLOSEurope PMCPMC
BibTeX
@misc{lewis2026pregabalin,
  title = {{PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial}},
  author = {G. Lewis and N. Freemantle and H.-M. Dehbi and C. Clarke and E. Bordea},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.01.26359217},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.01.26359217v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - PrEgabalin for Treatment Resistant generalised Anxiety disorder: statistical analysis plan for a randomised controlled trial
AU  - G. Lewis
AU  - N. Freemantle
AU  - H.-M. Dehbi
AU  - C. Clarke
AU  - E. Bordea
PY  - 2026
DA  - 2026/09/01
PB  - medRxiv
DO  - 10.64898/2026.09.01.26359217
UR  - https://www.medrxiv.org/content/10.64898/2026.09.01.26359217v1
AB  - This document describes the Statistical Analysis Plan (SAP) for PETRA, a randomised controlled trial in people with generalised anxiety disorder comparing pregabalin plus an antidepressant and standard care, with placebo plus an antidepressant and standard care, with respect to the primary outcome of the GAD-7 score at week 12.
ER  -